VERO venusconcept.com Kapitallashuvning sof aktivlarga nisbati

Venus Concept Inc (VERO) kompaniyasining rasmiy ramzlari

Yuqori qarzdorlik va lazer terapiyasining tor yo'nalishi kotirovkalarga salbiy ta'sir ko'rsatmoqda, bu esa narxning buki koeffitsiyenti tarixida yaqqol ko'rinadi. Ushbu metrikaning joriy darajasi 0.79 ni tashkil etadi. Shu bilan birga, Venus Concept Inc. (VERO) global B2B savdo tarmog'ini rivojlantirmoqda va tizimlar uchun hamyonbop obuna modeli ushbu uskunalarni klinikalarga ochiq qilib, barqaror pul oqimini ta'minlamoqda.

VERO Venus Concept Corporation: Balans qiymatiga nisbatan bozor qiymati 04.07.2022 - 16.02.2026 oraligʻida

VERO (Venus Concept Inc): tahliliy kesimlar va indikatorlar boʻyicha maʼlumotlar

- narx va narxlar bo'yicha konsensus prognoz:
Narx grafigi Venus Concept Inc.|VERO - Oʻrtacha prognoz narxi
- bozor kapitallashuvi bo'yicha ma'lumotlar:
Bozor bahosi Venus Concept Corp|VERO - Biznesning umumiy qiymati
- balans kapitallashuvi bo'yicha ma'lumotlar:
Bitta aksiya hisobiga balans qiymati Venus Concept|VERO - Kompaniyaning buxgalteriya qiymati|Bozor kapitallashuvining balans qiymatiga nisbati venusconcept.com|VERO - Kompaniya aktivlari
- qarz va likvidlik bo'yicha ma'lumotlar:
Qarzning xususiy kapitalga nisbati Venus Concept Inc.|VERO - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Qisqa muddatli qarzning kapitalga nisbati Venus Concept Corp|VERO - Kompaniyaning jamlangan qarzlari|Qarzning balans kapitallashuviga nisbati Venus Concept Corp|VERO - Uzoq muddatli majburiyatlar|Kompaniyaning qisqa muddatli qarzlari Venus Concept
Fundamental baholash:VERO Venus Concept Inc.
Venus Concept Inc original mahsuloti

Ushbu koeffitsient Venus Concept Inc. (VERO) aktivlarining adolatli qiymatini aniqlash uchun bazaviy mezon bo'lib xizmat qiladi. U bozor kapitalizatsiyasini sof balans qiymati bilan solishtirib, biznesning haddan tashqari qimmat yoki past baholanganligini aniqlaydi. Tarixiy P/BV koeffitsientini tahlil qilish orqali investor haqiqiy o'sishni spekulyativ narx tebranishlaridan ajratib olishi mumkin. Venus Concept Inc. (VERO) uchun ushbu metrikaning barqarorligi yuqori malakali muhandislarga va xodimlarni o'qitish dasturlariga kiritilgan investitsiyalarning samaradorligini tasdiqlaydi.

Raqobatchilar tahlili

Bozor qiymatining balans qiymatiga nisbati DXCM|Bozor qiymatining balans qiymatiga koeffitsiyenti penumbrainc.com|Novanta (NOVT) - Kapitallashuvning sof aktivlarga nisbati|Bozor kapitallashuvining balans qiymatiga multiplikatori Haemonetics Corp|Inspire Sleep (INSP) - Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati Procept (PRCT)|CNMD: Bozor kapitallashuvining balans qiymatiga nisbati|pulsebiosciences.com - Bozor qiymatining balans qiymatiga koeffitsiyenti|Bozor qiymatining balans qiymatiga nisbati InMode (INMD)|PMI - Balans qiymatiga nisbatan bozor qiymati|SRDX: Bozor kapitallashuvining balans qiymatiga nisbati|SENS (Senseonics Holdings, Inc.) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati NeuroPace, Inc. NPCE|Sof aktivlarga nisbatan bozor kapitallashuvi Tactile Systems Technology Inc.|SANUWAVE - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti Outset Medical Inc OM|Kapitallashuvning sof aktivlarga nisbati ELMD (Electromed)|LNSR - Bozor kapitallashuvining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati AVITA Medical, Inc. RCEL|PROF - Bozor kapitallashuvining balans qiymatiga multiplikatori|bairdmed.com - Bozor kapitallashuvining balans qiymatiga nisbati|EDAP TMS (EDAP) - Balans qiymatiga nisbatan bozor kapitallashuvi|Bozor kapitallashuvining balans qiymatiga nisbati APYX|Kapitallashuvning sof aktivlarga nisbati IceCure Medical, Ltd. (ICCM)|Pulmonx Corporation (LUNG) - Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati TELA (telabio.com)|CytoSorbents Corporation - Bozor qiymatining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati Sensus Healthcare Inc SRTS|ZYXI (Zynex Inc) - Bozor kapitallashuvining balans qiymatiga nisbati|ECOR - Bozor qiymatining balans qiymatiga koeffitsiyenti|Bozor kapitallashuvining balans qiymatiga nisbati vicarioussurgical.com|Inspira Technologies (IINN) - Kapitallashuvning balans qiymatiga nisbati|ICU: Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi IRIDEX Corp.|Bozor kapitallashuvining balans qiymatiga nisbati INBS (Intelligent Bio Solutions)|Kapitallashuvning sof aktivlarga nisbati beyondair.net (XAIR)|Bozor kapitallashuvining balans qiymatiga nisbati PFSA (Profusa Inc)|STRATA Skin Sciences Inc. - Bozor kapitallashuvining balans qiymatiga nisbati|GCTK - Bozor qiymatining balans qiymatiga nisbati|nanovibronix.com (NAOV) - Bozor qiymatining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati CHF Solutions NUWE|Aethlon Medical Corp (AEMD) - Balans qiymatiga nisbatan bozor qiymati|Bozor kapitallashuvining balans qiymatiga nisbati ASXC (Asensus Surgical Inc)|Bozor qiymatining balans qiymatiga koeffitsiyenti AVGR|BSGM: Bozor qiymatining balans qiymatiga nisbati|Bozor qiymatining xususiy kapitalga nisbati Cutera Inc. CUTR|Kapitallashuvning sof aktivlarga nisbati KNW (Know Labs Corp)|Bozor kapitallashuvining balans qiymatiga nisbati Inari Medical Corp NARI|Bozor kapitallashuvining balans qiymatiga nisbati NVRO (Nevro Corp.)|RSLS: Balans qiymatiga nisbatan bozor kapitallashuvi|Bozor qiymatining balans qiymatiga nisbati Silk Road Medical (SILK)